Area of research
Psychiatry and Mental health · Neurology
Research interest
Research focused on Placebo and Migraine, with related work in Double blind, Posterior cingulate, Prodrome. Notable publications include 'Atogepant for the Preventive Treatment of Migraine', 'Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial', and 'Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Computed Tomography Study'.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
Atogepant for the Preventive Treatment of Migraine
It's tricky: Rating alleviating maneuvers in cervical dystonia
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults
Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Computed Tomography Study